Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial

Our study indicate that compared with corticosteroids, bevacizumab offers improved symptomatic relief and radiographic response.